GCM
GSK icon

Genus Capital Management’s GSK GSK Stock Holding History

Genus Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,017
Closed -$339K – 267
2024
Q4 		$339K Hold
10,017
– – 0.05% 157
2024
Q3 		$409K Buy
10,017
+960
+11% +$39.3K 0.05% 154
2024
Q2 		$349K Buy
+9,057
New +$381K 0.05% 160
2024
Q1 		– Sell
-8,850
Closed -$328K – 286
2023
Q4 		$328K Buy
+8,850
New +$318K 0.05% 162

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Genus Capital Management's GSK Position: Q2 2026 in Review

Genus Capital Management reduced its GSK (GSK) stake by 2.4% in Q2 2026, selling an estimated $15.9K and leaving 12,210 shares worth $640K. The position accounts for 0.06% of the portfolio, ranked #158.

Genus Capital Management first reported a position in GSK in Q2 2023 and has held it in 9 quarters since. The position peaked at $690K in Q1 2026. 477 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Genus Capital Management held 12,210 shares of GSK worth $640K as of Q2 2026.
  • Genus Capital Management sold 300 GSK shares in Q2 2026, an estimated $15.9K.
  • GSK made up 0.06% of Genus Capital Management's portfolio in Q2 2026, its #158 holding.
  • Genus Capital Management first reported a position in GSK in Q2 2023 and has held it in 9 quarters since.
  • Genus Capital Management's GSK position peaked at $690K in Q1 2026.
  • 477 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.